{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:23:30Z","timestamp":1784953410906,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41366-026-02037-y","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:15:37Z","timestamp":1772518537000},"page":"1087-1096","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Weight-related changes in MRI-derived measures of body composition and liver steatosis: a large-scale analysis for obesity trial design"],"prefix":"10.1038","volume":"50","author":[{"given":"Magdalena","family":"Nowak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Duncker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6301-2696","authenticated-orcid":false,"given":"Lee M.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1127-9425","authenticated-orcid":false,"given":"Steve B.","family":"Heymsfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0774-6983","authenticated-orcid":false,"given":"Helena","family":"Thomaides Brears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy D.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4235-4694","authenticated-orcid":false,"given":"E. Louise","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2037_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","volume":"405","author":"M Ng","year":"2025","unstructured":"Ng M, Gakidou E, Lo J, Abate YH, Abbafati C, Abbas N, et al. Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405:813\u201338.","journal-title":"Lancet"},{"key":"2037_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diab Endocrinol. 2025;13:221\u201362.","journal-title":"Lancet Diab Endocrinol"},{"key":"2037_CR3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41380-024-02737-9","volume":"30","author":"S Saeed","year":"2025","unstructured":"Saeed S, Bonnefond A, Froguel P. Obesity: exploring its connection to brain function through genetic and genomic perspectives. Mol Psychiatry. 2025;30:651\u20138.","journal-title":"Mol Psychiatry"},{"key":"2037_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8:20\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2037_CR5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105467","volume":"110","author":"M Jung","year":"2024","unstructured":"Jung M, Raghu VK, Reisert M, Rieder H, Rospleszcz S, Pischon T, et al. Deep learning-based body composition analysis from whole-body magnetic resonance imaging to predict all-cause mortality in a large western population. EBioMedicine. 2024;110:105467.","journal-title":"EBioMedicine"},{"key":"2037_CR6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1017\/S0954422412000054","volume":"25","author":"EL Thomas","year":"2012","unstructured":"Thomas EL, Frost G, Taylor-Robinson SD, Bell JD. Excess body fat in obese and normal-weight subjects. Nutr Res Rev. 2012;25:150\u201361.","journal-title":"Nutr Res Rev"},{"key":"2037_CR7","volume":"10","author":"Y Liu","year":"2022","unstructured":"Liu Y, Basty N, Whitcher B, Bell JD, Sorokin EP, van Bruggen N, et al. Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning. eLife. 2022;10:e65554.","journal-title":"eLife"},{"key":"2037_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcmg.2023.07.014","volume":"17","author":"ACdoAH Souza","year":"2024","unstructured":"Souza ACdoAH, Rosenthal MH, Moura FA, Divakaran S, Osborne MT, Hainer J, et al. Body composition, coronary microvascular dysfunction, and future risk of cardiovascular events including heart failure. JACC Cardiovasc Imaging. 2024;17:179\u201391.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2037_CR9","doi-asserted-by":"publisher","unstructured":"Liu L, Li Z, Ye W, Peng P, Wang Y, Wan L et al. Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis. eClinicalMedicine. 2025;79. https:\/\/doi.org\/10.1016\/j.eclinm.2024.103020.","DOI":"10.1016\/j.eclinm.2024.103020"},{"key":"2037_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13098-023-01085-y","volume":"15","author":"X Wang","year":"2023","unstructured":"Wang X, Wu N, Sun C, Jin D, Lu H. Effects of SGLT-2 inhibitors on adipose tissue distribution in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2023;15:113.","journal-title":"Diabetol Metab Syndr"},{"key":"2037_CR11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(22)00070-5","volume":"10","author":"A Gastaldelli","year":"2022","unstructured":"Gastaldelli A, Cusi K, Fern\u00e1ndez Land\u00f3 L, Bray R, Brouwers B, Rodr\u00edguez \u00c1. Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. Lancet Diab Endocrinol. 2022;10:393\u2013406.","journal-title":"Lancet Diab Endocrinol"},{"key":"2037_CR12","doi-asserted-by":"publisher","unstructured":"Kramer CM, Borlaug BA, Zile MR, Ruff D, DiMaria JM, Menon V et al. Tirzepatide reduces LV mass and paracardiac adipose tissue in obesity-related heart failure. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2024.11.001.","DOI":"10.1016\/j.jacc.2024.11.001"},{"key":"2037_CR13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","volume":"391","author":"R Loomba","year":"2024","unstructured":"Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, et al. Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis. N Engl J Med. 2024;391:299\u2013310.","journal-title":"N Engl J Med"},{"key":"2037_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jama.2024.6586","volume":"332","author":"C Conte","year":"2024","unstructured":"Conte C, Hall KD, Klein S. Is weight loss-induced muscle mass loss clinically relevant?. JAMA. 2024;332:9\u201310.","journal-title":"JAMA"},{"key":"2037_CR15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2213-8587(24)00272-9","volume":"12","author":"CM Prado","year":"2024","unstructured":"Prado CM, Phillips SM, Gonzalez MC, Heymsfield SB. Muscle matters: the effects of medically induced weight loss on skeletal muscle. Lancet Diab Endocrinol. 2024;12:785\u20137.","journal-title":"Lancet Diab Endocrinol"},{"key":"2037_CR16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41391-021-00442-0","volume":"25","author":"P Lopez","year":"2022","unstructured":"Lopez P, Newton RU, Taaffe DR, Singh F, Buffart LM, Spry N, et al. Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis. Prostate Cancer Prostatic Dis. 2022;25:615\u201326.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2037_CR17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","volume":"57","author":"SS Shachar","year":"2016","unstructured":"Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58\u201367.","journal-title":"Eur J Cancer"},{"key":"2037_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jim-2018-000722","volume":"66","author":"M Borga","year":"2018","unstructured":"Borga M, West J, Bell JD, Harvey NC, Romu T, Heymsfield SB, et al. Advanced body composition assessment: from body mass index to body composition profiling. J invest Med. 2018;66:1\u20139.","journal-title":"J invest Med"},{"key":"2037_CR19","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-023-01063-w","volume":"23","author":"S Mouchti","year":"2023","unstructured":"Mouchti S, Orliacq J, Reeves G, Chen Z. Assessment of correlation between conventional anthropometric and imaging-derived measures of body fat composition: a systematic literature review and meta-analysis of observational studies. BMC Med Imaging. 2023;23:127.","journal-title":"BMC Med Imaging"},{"key":"2037_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s44352-025-00005-2","volume":"2","author":"M Nowak","year":"2025","unstructured":"Nowak M, N\u00fa\u00f1ez L, Hill CE, Davis T, Cardiel LF, Schooler GR, et al. Repeatability, reproducibility, and observer variability of body composition assessment with single-slice lumbar MRI. Discov Imaging. 2025;2:1.","journal-title":"Discov Imaging"},{"key":"2037_CR21","doi-asserted-by":"publisher","unstructured":"Nowak M, Nunez L, Hill CE, Pagliaro T, McGonnigle J, Niglas M et al. Automated volumetric MRI quantification of body fat and skeletal muscle in the UK Biobank: technical validation against expert manual segmentations and comparison with single-slice techniques. Abdomimal Radiol. 2025. https:\/\/doi.org\/10.1007\/s00261-025-05170-w.","DOI":"10.1007\/s00261-025-05170-w"},{"key":"2037_CR22","doi-asserted-by":"crossref","first-page":"e0249491","DOI":"10.1371\/journal.pone.0249491","volume":"16","author":"C Beyer","year":"2021","unstructured":"Beyer C, Hutton C, Andersson A, Imajo K, Nkajima A, Kiker D, et al. Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort. PLOS ONE. 2021;16:e0249491.","journal-title":"PLOS ONE"},{"key":"2037_CR23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2017170550","volume":"286","author":"T Yokoo","year":"2018","unstructured":"Yokoo T, Serai S, Pirasteh A, Bashir M, Hamilton G, Hernando D, et al. Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology. 2018;286:486\u201398.","journal-title":"Radiology"},{"key":"2037_CR24","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779\u2013e1001779.","journal-title":"PLoS Med"},{"key":"2037_CR25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ijo.2017.289","volume":"42","author":"SK Vasan","year":"2018","unstructured":"Vasan SK, Osmond C, Canoy D, Christodoulides C, Neville MJ, Di Gravio C, et al. Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk. Int J Obes. 2018;42:850\u20137.","journal-title":"Int J Obes"},{"key":"2037_CR26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2023.05.046","volume":"79","author":"A Roca-Fernandez","year":"2023","unstructured":"Roca-Fernandez A, Banerjee R, Thomaides-Brears H, Telford A, Sanyal A, Neubauer S, et al. Liver disease is a significant risk factor for cardiovascular outcomes - a UK Biobank study. J Hepatol. 2023;79:1085\u201395.","journal-title":"J Hepatol"},{"key":"2037_CR27","doi-asserted-by":"crossref","first-page":"e0214921","DOI":"10.1371\/journal.pone.0214921","volume":"14","author":"V Bachtiar","year":"2019","unstructured":"Bachtiar V, Kelly MD, Wilman HR, Jacobs J, Newbould R, Kelly CJ, et al. Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver. PloS one. 2019;14:e0214921.","journal-title":"PloS one"},{"key":"2037_CR28","doi-asserted-by":"publisher","unstructured":"Paige E, Korda RJ, Banks E, Rodgers B. How weight change is modelled in population studies can affect research findings: empirical results from a large-scale cohort study. BMJ Open. 2014. https:\/\/doi.org\/10.1136\/bmjopen-2014-004860.","DOI":"10.1136\/bmjopen-2014-004860"},{"key":"2037_CR29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","volume":"402","author":"WT Garvey","year":"2023","unstructured":"Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402:613\u201326.","journal-title":"Lancet"},{"key":"2037_CR30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","volume":"392","author":"AM Jastreboff","year":"2025","unstructured":"Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, et al. Tirzepatide for obesity treatment and diabetes prevention. N Engl J Med. 2025;392:958\u201371.","journal-title":"N Engl J Med"},{"key":"2037_CR31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989\u20131002.","journal-title":"N Engl J Med"},{"key":"2037_CR32","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","volume":"325","author":"D Rubino","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021;325:1414\u201325.","journal-title":"JAMA"},{"key":"2037_CR33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","volume":"397","author":"M Davies","year":"2021","unstructured":"Davies M, F\u00e6rch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, et al. Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397:971\u201384.","journal-title":"Lancet"},{"key":"2037_CR34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13679-017-0262-y","volume":"6","author":"DH Ryan","year":"2017","unstructured":"Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. 2017;6:187\u201394.","journal-title":"Curr Obes Rep"},{"key":"2037_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","volume":"22","author":"WT Garvey","year":"2016","unstructured":"Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pr. 2016;22:1\u2013203.","journal-title":"Endocr Pr"},{"key":"2037_CR36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.2047-6310.2012.00064.x","volume":"7","author":"TJ Cole","year":"2012","unstructured":"Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes. 2012;7:284\u201394.","journal-title":"Pediatr Obes"},{"key":"2037_CR37","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386.","journal-title":"Hepatology"},{"key":"2037_CR38","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797\u2013835.","journal-title":"Hepatology"},{"key":"2037_CR39","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.cgh.2021.09.041","volume":"20","author":"A Andersson","year":"2022","unstructured":"Andersson A, Kelly M, Imajo K, Nakajima A, Fallowfield JA, Hirschfield G, et al. Clinical utility of magnetic resonance imaging biomarkers for identifying nonalcoholic steatohepatitis patients at high risk of progression: a multicenter pooled data and meta-analysis. Clin Gastroenterol Hepatol. 2022;20:2451\u20132461.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2037_CR40","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"American Diabetes Association Professional Practice Committee.","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diab Care. 2025;48:S27\u2013S49.","journal-title":"Diab Care"},{"key":"2037_CR41","doi-asserted-by":"publisher","unstructured":"Morieri ML, Rigato M, Frison V, D\u2019Ambrosio M, Sartore G, Avogaro A et al. Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study. Diabetologia. 2025. https:\/\/doi.org\/10.1007\/s00125-025-06402-w.","DOI":"10.1007\/s00125-025-06402-w"},{"key":"2037_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinme.2024.100206","volume":"24","author":"S Ansari","year":"2024","unstructured":"Ansari S, Mazaheri T, O\u2019Donnell K, Waite M, Cann A, Abdel-Malek M, et al. Time to unshackle the medical treatment of obesity in the NHS. Clin Med. 2024;24:100206.","journal-title":"Clin Med"},{"key":"2037_CR43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15277\/bjdvd.2014.015","volume":"14","author":"KY Thong","year":"2014","unstructured":"Thong KY, Gupta PS, Cull ML, Adamson KA, Dove DS, Rowles SV, et al. GLP-1 receptor agonists in type 2 diabetes - NICE guidelines versus clinical practice. Br J Diab. 2014;14:52\u201359.","journal-title":"Br J Diab"},{"key":"2037_CR44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S2213-8587(21)00179-0","volume":"9","author":"IJ Neeland","year":"2021","unstructured":"Neeland IJ, Marso SP, Ayers CR, Lewis B, Oslica R, Francis W, et al. Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial. Lancet Diab Endocrinol. 2021;9:595\u2013605.","journal-title":"Lancet Diab Endocrinol"},{"key":"2037_CR45","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jcsm.12834","volume":"12","author":"J Linge","year":"2021","unstructured":"Linge J, Petersson M, Forsgren MF, Sanyal AJ, Dahlqvist Leinhard O. Adverse muscle composition predicts all-cause mortality in the UK Biobank imaging study. J Cachexia Sarcopenia Muscle. 2021;12:1513\u201326.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2037_CR46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-07556-y","volume":"12","author":"B Whitcher","year":"2022","unstructured":"Whitcher B, Thanaj M, Cule M, Liu Y, Basty N, Sorokin EP, et al. Precision MRI phenotyping enables detection of small changes in body composition for longitudinal cohorts. Sci Rep. 2022;12:3748.","journal-title":"Sci Rep"},{"key":"2037_CR47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.metabol.2018.04.003","volume":"85","author":"A Maltais","year":"2018","unstructured":"Maltais A, Alm\u00e9ras N, Lemieux I, Tremblay A, Bergeron J, Poirier P, et al. Trunk muscle quality assessed by computed tomography: association with adiposity indices and glucose tolerance in men. Metab Clin Exp. 2018;85:205\u201312.","journal-title":"Metab Clin Exp"},{"key":"2037_CR48","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13841","volume":"26","author":"JI Mechanick","year":"2025","unstructured":"Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, et al. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2025;26:e13841.","journal-title":"Obes Rev"},{"key":"2037_CR49","volume":"161","author":"K Stefanakis","year":"2024","unstructured":"Stefanakis K, Kokkorakis M, Mantzoros CS. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation. Metabolism. 2024;161:156057.","journal-title":"Metabolism"},{"key":"2037_CR50","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae164","volume":"8","author":"GM Tinsley","year":"2024","unstructured":"Tinsley GM, Heymsfield SB. Fundamental body composition principles provide context for fat-free and skeletal muscle loss with GLP-1 RA treatments. J Endocr Soc. 2024;8:bvae164.","journal-title":"J Endocr Soc"},{"key":"2037_CR51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cmet.2016.02.005","volume":"23","author":"F Magkos","year":"2016","unstructured":"Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23:591\u2013601.","journal-title":"Cell Metab"},{"key":"2037_CR52","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/jcsm.13445","volume":"15","author":"A Pandey","year":"2024","unstructured":"Pandey A, Patel KV, Segar MW, Ayers C, Linge J, Leinhard OD, et al. Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial. J Cachexia Sarcopenia Muscle. 2024;15:1072\u201383.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2037_CR53","doi-asserted-by":"publisher","unstructured":"Sattar N, Neeland IJ, Leinhard OD, Land\u00f3 LF, Bray R, Linge J et al. Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial. Lancet Diabetes Endocrinol. 2025. https:\/\/doi.org\/10.1016\/S2213-8587(25)00027-0.","DOI":"10.1016\/S2213-8587(25)00027-0"},{"key":"2037_CR54","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/ajcn\/80.5.1215","volume":"80","author":"SJ Lee","year":"2004","unstructured":"Lee SJ, Janssen I, Heymsfield SB, Ross R. Relation between whole-body and regional measures of human skeletal muscle. Am J Clin Nutr. 2004;80:1215\u201321.","journal-title":"Am J Clin Nutr"},{"key":"2037_CR55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1152\/japplphysiol.00309.2016","volume":"121","author":"A Yaskolka Meir","year":"2016","unstructured":"Yaskolka Meir A, Shelef I, Schwarzfuchs D, Gepner Y, Tene L, Zelicha H, et al. Intermuscular adipose tissue and thigh muscle area dynamics during an 18-month randomized weight loss trial. J Appl Physiol. 2016;121:518\u201327.","journal-title":"J Appl Physiol"},{"key":"2037_CR56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jhep.2024.08.031","volume":"82","author":"N Alkhouri","year":"2025","unstructured":"Alkhouri N, Beyer C, Shumbayawonda E, Andersson A, Yale K, Rolph T, et al. Decreases in cT1 and liver fat content reflect treatment-induced histological improvements in MASH. J Hepatol. 2025;82:438\u201345.","journal-title":"J Hepatol"},{"key":"2037_CR57","doi-asserted-by":"publisher","unstructured":"M\u00e1tis D, Hegyi P, Teutsch B, Tornai T, Er\u0151ss B, P\u00e1r G et al. Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies. Front Med. 2023;10. https:\/\/doi.org\/10.3389\/fmed.2023.1114836.","DOI":"10.3389\/fmed.2023.1114836"},{"key":"2037_CR58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jcsm.13397","volume":"15","author":"D Kim","year":"2024","unstructured":"Kim D, Lee J, Park R, Oh C-M, Moon S. Association of low muscle mass and obesity with increased all-cause and cardiovascular disease mortality in US adults. J Cachexia Sarcopenia Muscle. 2024;15:240\u201354.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2037_CR59","doi-asserted-by":"crossref","unstructured":"Basty N, Thanaj M, Whitcher B, Bell JD, Thomas EL. Comparing DXA and MRI body composition measurements in cross-sectional and longitudinal cohorts. medRxiv. 2024, https:\/\/www.medrxiv.org\/content\/10.1101\/2024.12.12.24318943v1.full.","DOI":"10.1101\/2024.12.12.24318943"},{"key":"2037_CR60","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1111\/dom.15913","volume":"26","author":"RL Dubin","year":"2024","unstructured":"Dubin RL, Heymsfield SB, Ravussin E, Greenway FL. Glucagon-like peptide-1 receptor agonist-based agents and weight loss composition: filling the gaps. Diab Obes Metab. 2024;26:5503\u201318.","journal-title":"Diab Obes Metab"}],"updated-by":[{"DOI":"10.1038\/s41366-026-02102-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000}}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02037-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:02:05Z","timestamp":1780437725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02037-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02037-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6656623\/v1","asserted-by":"object"}]},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article, the author name E. Louise Thomas has been erroneously published as Louise E. Thomas.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41366-026-02102-6","URL":"https:\/\/doi.org\/10.1038\/s41366-026-02102-6","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. MN, LN, TP, MDR, and HTB are employees for Perspectum, a company that has developed LiverMultiScan, a UKCA and FDA 510(k)\u2013cleared medical device for liver health measurements that was used in the imaging sub-study of the UK Biobank. HTB and MDR are also shareholders of Perspectum. LN and TP were employees of Perspectum during this work and Carlos Duncker became an employee of Perspectum after this work was completed. ELT and JDB are consultants for Perspectum. LMK is a consultant to Altimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Cytoki, Helicore, Johnson & Johnson, Kallyope, Eli Lilly & Company, MetaVia, Neurogastrx, Novo Nordisk, Oxford Medical Products, Perspectum, Pfizer, Skye Bioscience and Zealand. SBH is on the medical advisory boards of Lilly, Abbott, Tanita Corp., Novo Nordisk, and Regeneron. The remaining authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}